Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

This story appears in the January 2012 issue of National Geographic magazine. Every summer, on the first weekend in August, thousands of twins converge on Twinsburg, Ohio, a small town southeast of ...